Original Article
Outcomes of expanded use of PCA3 testing in a Spanish population with clinical suspicion of prostate cancer
Resultados del uso expandido del PCA3 score en una población española con sospecha de cáncer de próstata
Read
2069
Timeswas read the article
865
Total PDF
1204
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 4 | 4 |
| 2025 11 | 0 | 10 | 10 |
| 2025 10 | 0 | 15 | 15 |
| 2025 9 | 0 | 19 | 19 |
| 2025 8 | 0 | 23 | 23 |
| 2025 7 | 0 | 4 | 4 |
| 2025 6 | 0 | 3 | 3 |
| 2025 5 | 0 | 6 | 6 |
| 2025 4 | 0 | 1 | 1 |
| 2025 3 | 0 | 4 | 4 |
| 2025 2 | 0 | 8 | 8 |
| 2025 1 | 0 | 2 | 2 |
| 2024 12 | 0 | 5 | 5 |
| 2024 11 | 0 | 9 | 9 |
| 2024 10 | 0 | 10 | 10 |
| 2024 9 | 0 | 15 | 15 |
| 2024 8 | 0 | 6 | 6 |
| 2024 7 | 0 | 8 | 8 |
| 2024 6 | 0 | 3 | 3 |
| 2024 5 | 0 | 6 | 6 |
| 2024 4 | 0 | 14 | 14 |
| 2024 3 | 0 | 5 | 5 |
| 2024 2 | 0 | 10 | 10 |
| 2024 1 | 0 | 8 | 8 |
| 2023 12 | 0 | 5 | 5 |
| 2023 11 | 0 | 12 | 12 |
| 2023 10 | 0 | 28 | 28 |
| 2023 9 | 0 | 10 | 10 |
| 2023 8 | 0 | 14 | 14 |
| 2023 7 | 0 | 29 | 29 |
| 2023 6 | 0 | 9 | 9 |
| 2023 5 | 0 | 6 | 6 |
| 2023 4 | 0 | 4 | 4 |
| 2023 3 | 0 | 4 | 4 |
| 2023 2 | 0 | 11 | 11 |
| 2023 1 | 0 | 6 | 6 |
| 2022 12 | 0 | 10 | 10 |
| 2022 11 | 0 | 8 | 8 |
| 2022 10 | 0 | 9 | 9 |
| 2022 9 | 0 | 25 | 25 |
| 2022 8 | 0 | 6 | 6 |
| 2022 7 | 0 | 6 | 6 |
| 2022 6 | 0 | 2 | 2 |
| 2022 5 | 0 | 9 | 9 |
| 2022 4 | 0 | 6 | 6 |
| 2022 3 | 0 | 13 | 13 |
| 2022 2 | 0 | 4 | 4 |
| 2022 1 | 0 | 6 | 6 |
| 2021 12 | 0 | 3 | 3 |
| 2021 11 | 0 | 3 | 3 |
| 2021 10 | 0 | 13 | 13 |
| 2021 9 | 0 | 4 | 4 |
| 2021 8 | 0 | 13 | 13 |
| 2021 7 | 0 | 6 | 6 |
| 2021 6 | 0 | 1 | 1 |
| 2021 5 | 0 | 2 | 2 |
| 2021 4 | 0 | 5 | 5 |
| 2021 3 | 0 | 6 | 6 |
| 2021 2 | 0 | 2 | 2 |
| 2021 1 | 0 | 5 | 5 |
| 2020 12 | 0 | 3 | 3 |
| 2020 11 | 0 | 5 | 5 |
| 2020 8 | 0 | 3 | 3 |
| 2020 6 | 0 | 4 | 4 |
| 2020 5 | 0 | 6 | 6 |
| 2020 4 | 0 | 1 | 1 |
| 2020 3 | 0 | 2 | 2 |
| 2020 1 | 0 | 5 | 5 |
| 2019 12 | 0 | 5 | 5 |
| 2019 10 | 0 | 4 | 4 |
| 2019 9 | 0 | 4 | 4 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 4 | 4 |
| 2019 6 | 0 | 7 | 7 |
| 2019 5 | 0 | 48 | 48 |
| 2018 2 | 10 | 0 | 10 |
| 2018 1 | 21 | 0 | 21 |
| 2017 12 | 8 | 0 | 8 |
| 2017 11 | 24 | 3 | 27 |
| 2017 10 | 17 | 3 | 20 |
| 2017 9 | 15 | 5 | 20 |
| 2017 8 | 19 | 2 | 21 |
| 2017 7 | 17 | 6 | 23 |
| 2017 6 | 25 | 4 | 29 |
| 2017 5 | 27 | 8 | 35 |
| 2017 4 | 32 | 16 | 48 |
| 2017 3 | 29 | 10 | 39 |
| 2017 2 | 28 | 0 | 28 |
| 2017 1 | 26 | 0 | 26 |
| 2016 12 | 28 | 7 | 35 |
| 2016 11 | 26 | 2 | 28 |
| 2016 10 | 35 | 5 | 40 |
| 2016 9 | 31 | 2 | 33 |
| 2016 8 | 28 | 2 | 30 |
| 2016 7 | 17 | 1 | 18 |
| 2016 6 | 20 | 3 | 23 |
| 2016 5 | 18 | 10 | 28 |
| 2016 4 | 31 | 8 | 39 |
| 2016 3 | 39 | 14 | 53 |
| 2016 2 | 33 | 13 | 46 |
| 2016 1 | 32 | 16 | 48 |
| 2015 12 | 17 | 11 | 28 |
| 2015 11 | 13 | 9 | 22 |
| 2015 10 | 20 | 5 | 25 |
| 2015 9 | 16 | 5 | 21 |
| 2015 8 | 22 | 5 | 27 |
| 2015 7 | 10 | 3 | 13 |
| 2015 6 | 8 | 3 | 11 |
| 2015 5 | 12 | 2 | 14 |
| 2015 4 | 26 | 8 | 34 |
| 2015 3 | 15 | 4 | 19 |
| 2015 2 | 14 | 0 | 14 |
| 2015 1 | 25 | 3 | 28 |
| 2014 12 | 31 | 7 | 38 |
| 2014 11 | 16 | 4 | 20 |
| 2014 10 | 38 | 5 | 43 |
| 2014 9 | 39 | 4 | 43 |
| 2014 8 | 26 | 3 | 29 |
| 2014 7 | 32 | 1 | 33 |
| 2014 6 | 19 | 4 | 23 |
| 2014 5 | 17 | 2 | 19 |
| 2014 4 | 13 | 5 | 18 |
| 2014 3 | 24 | 3 | 27 |
| 2014 2 | 17 | 3 | 20 |
| 2014 1 | 10 | 4 | 14 |
| 2013 12 | 35 | 4 | 39 |
| 2013 11 | 25 | 5 | 30 |
| 2013 10 | 15 | 7 | 22 |
| 2013 9 | 13 | 1 | 14 |
Show all
